CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
APAC
CANADA

About Us

Conference

Partner With Us

  • Europe
    • US
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Biotech
    Cancer Immunotherapy
    Cell and Gene Therapy Companies
    Clinical Trial Management
    Drug Discovery and Development
    Genomics
    Therapeutics
    Women's Health
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    CDMO
    Clinical Laboratory Services
    CRO
    Microgravity R&D
    Supplements
  • Business Services
    Clinical Research Training
    Life Science Consulting
    Life Science Logistics
    Life Science Marketing
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Nucleus RadioPharma

Lauren Derose, Director of Quality

Quality Leadership in Radiopharmaceutical Manufacturing

Lauren Derose

Lauren Derose

Manufacturing Quality Steward

Integrating Quality into Every Stage of Manufacturing


Quality leadership begins with building strong partnerships across an organization to create and sustain a culture of quality. Quality cannot operate successfully in isolation. It requires shared ownership and collaboration among Quality, Manufacturing, Quality Control, Engineering, Validation, Development, Supply Chain, and leadership.


This is especially important in radiopharmaceutical manufacturing because of the combination of sterile processing, radioactive materials, short product half-lives, compressed manufacturing timelines, and patient safety considerations. Quality must be integrated into operations from the beginning rather than viewed as a final checkpoint.


A strong Quality organization provides independent oversight while partnering with teams to ensure processes are scientifically sound, risk-based, compliant, and practical. Quality leaders must also be willing to identify and escalate risk when necessary. The strongest quality cultures are those where everyone understands that quality and patient safety are shared responsibilities.


Integrating Quality into Every Stage of Manufacturing


I do not view Quality and Operations as opposing functions. The best Quality systems enable manufacturing while maintaining appropriate controls and protecting the patient. The key is to understand the intent behind regulatory requirements and apply them based on product, process, and patient risk.


Quality should be involved early in manufacturing readiness, equipment qualification, validation, technology transfer, and process development. When Quality is involved from the beginning, compliance can be built into the process rather than added afterward. I also believe Quality should strive to bring possible solutions, not simply identify problems.


There are times when Quality must say something cannot move forward, but that conversation should explain the concern, identify the risk, and, whenever possible, provide a compliant path forward.


Scaling Quality Systems alongside Growing Operations


One of the greatest challenges is ensuring that the Quality Management System grows at the same pace as the operation. This can be particularly challenging in radiopharmaceutical startups, where facilities, equipment, processes, products, and teams may all be developing simultaneously. Compared with more traditional pharmaceutical environments, the experiences and lessons learned can come very quickly.


Quality leaders must be able to take those lessons, evaluate the risk, and translate them into stronger procedures, controls, training, and future ways of working. This creates an accelerated learning environment.


A strong quality organization captures those lessons and uses them to improve the next process, project, or program continuously.


You may be qualifying equipment, preparing a facility, introducing a new product, developing procedures, training employees, and addressing unexpected technical challenges at the same time. The challenge is not simply moving faster— it is learning faster without compromising quality. A strong quality organization captures those lessons and uses them to improve the next process, project, or program continuously.


Evolving Quality Management through Risk-Based Thinking


A mature Quality Management System cannot be static. Regulations, guidance, industry standards, technology, and scientific understanding continue to evolve, and Quality organizations must evolve with them. Quality leaders should continuously evaluate whether their systems remain appropriate for the products and operations they support.


This includes monitoring regulatory developments, reviewing trends from deviations and investigations, assessing audit findings, evaluating performance metrics, and identifying recurring risks before they become larger issues. I strongly believe in risk-based quality management. The objective should not simply be to create more procedures or documentation. It should be to understand where meaningful risks exist and establish effective controls while continuously improving the operation.


Building Trust through Hands-On Quality Leadership


Learn more than Quality, stay adaptable, and be willing to jump in and help. The strongest Quality leaders understand how Manufacturing, QC, Engineering, Validation, Development, and Supply Chain actually operate. Spend time with the people doing the work, ask questions, and understand the science and processes behind the decisions you are making.


Do not let your title make you feel that a task is beneath you or that you cannot step in to help. Leadership is not just about directing others. Sometimes it means getting into the details, helping a team work through an issue, or stepping in wherever your experience can add value. Radiopharmaceutical and startup environments can provide tremendous opportunities to learn because challenges and responsibilities often come quickly.


Stay curious, adaptable, and humble. Maintain your professional judgment and integrity, but remember that Quality leadership is ultimately about partnership. Successful Quality leaders are not defined by their titles. They are defined by their ability to adapt, solve problems, support their teams, build trust, and create a culture where everyone takes ownership of quality and patient safety.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.

Editorial Lens

Radiopharmaceutical manufacturing presents distinctive quality challenges where compressed production timelines, regulatory demands and patient safety require exceptional operational discipline. For life sciences executives and quality leaders, embedding risk-based oversight into manufacturing processes, strengthening cross-functional accountability and adapting quality systems to operational growth are essential to maintaining compliance and safeguarding patients.

The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    Veracyte, Inc [NASDAQ: VCYT]

    Leveraging Genomics for Personalised Healthcare

    Martin Bostrup, Executive Director, Market Access & Medical Affairs, EMEA

  • Willis Towers Watson

    Alvotech [NASDAQ: ALVO]

    Adopting Blockchain Technology for Clinical Trial Management

    Tomaz Vaupotic, Senior Director, Head of Clinical & Medical Quality

  • Willis Towers Watson

    Novo Nordisk [CPH: NOVO-B]

    Real-World Evidence Empowering Patient-Focused Medical Affairs

    Jesper Lekdorf, VP Global Medical Affairs

  • Willis Towers Watson

    Recordati S.p.A [BIT: REC]

    Navigating Through Drug Discovery and Development

    Stefano Biondi, VP of Pre-Clinical

{literal}{/literal}
Life Sciences Review Europe
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review Europe. All rights reserved.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesrevieweurope.com/leadership-perspective/quality-leadership-in-radiopharmaceutical-manufacturing-nwid-3885.html